This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at firstname.lastname@example.org or call 800-767-3771 ext. 9339.
For Immediate Release
Chicago, IL – February 22, 2012 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include CBS Corporation (CBS - Analyst Report), Netflix Inc (NFLX - Analyst Report), Amazon. Com. Inc (AMZN - Analyst Report), Monsanto Company (MON - Analyst Report) and Syngenta AG (SYT - Analyst Report).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Tuesday’s Analyst Blog:
Earnings Scorecard: CBS Corporation
CBS Corporation (CBS - Analyst Report) reported better-than-expected fourth-quarter 2011 earnings on February 15, 2012. The Wall Street analysts had almost a week to ponder on the earnings results and eventually make their estimates revision.
Below we will cover the results of the recent earnings announcement, subsequent estimate revisions by analysts as well as the Zacks Rank and long-term recommendation for the stock.
Earnings Report Review
CBS Corporation’s quarterly earnings of 57 cents a share surpassed the Zacks Consensus Estimate of 53 cents and jumped 23.9% from 46 cents in the year-ago quarter.
Significant political advertising revenues and the second-cycle syndication of CSI, which boosted the prior-year quarter’s results, were not there during the reported quarter. Thus, revenue declined 3.1% year over year to $3.78 billion and missed the Zacks Consensus Estimate of $3.92 billion.
(Read our full coverage on this earnings report: CBS Reports Better Than Expected)
Earnings Estimate Revisions - Overview
Since the earning release, estimates for CBS Corporation displayed an uptrend, reflecting that the analysts are optimistic on the company. This seems to be good news, and now let’s get into the details of the earnings estimate.
Agreement of Estimate Revisions
Clearly, a positive sentiment is evident among analysts, signifying that they are hopeful on the company’s future earnings outlook. In the last seven days, of the 24 analysts covering the stock, 16 have raised estimates for 2012, while none lowered the same.
Looking out to fiscal 2013, story remains the same as 7 analysts raised their earnings estimates, while none moved in the opposite direction.
The upward revision signifies that the analysts remain confident about advertising continuing its momentum in 2012. Political advertising estimates are very high (around $8B) for 2012 for being the year of Presidential election and CBS Corporation being the largest television station in U.S., is expected to benefit largely on this front.
Moreover, the company’s effective cost-control measures and growth in high margin revenue coming from streaming deals, increased international syndication revenue and retransmission fees will lead to margin expansion in quarters to come.
Turning to the current quarter, analysts’ sentiment remained mixed. In the last 7 days, 3 analysts raised their estimates, while 2 lowered the same. For the second-quarter 2012, 4 analysts made an upward revision, while 2 moved in the opposite direction.
Some of the analysts are cautious about the accelerated ad growth during the year. Further, the lingering macro-economic headwinds are adding fuel to the fire.
Magnitude of Estimate Revisions
In the last 7 days, the Zacks Consensus Estimate for fiscal 2012 and 2013 increased by 4 cents to $2.33 and $2.63, respectively.
Estimates haven’t budged for CBS Corporation’s first-quarter 2012, the Zacks Consensus Estimate remained stable at 43 cents, and for the second-quarter 2012, it inched up a penny to 60 cents a share in the last 7 days.
The current Zacks Consensus Estimate for first-quarter 2012 is pegged in the range from a low of 38 cents to a high of 51 cents. For fiscal 2012, the estimates range from $2.16 to $2.45.
CBS remains well positioned to drive revenue growth in the coming quarters through its strategic initiatives and operating efficiencies. Management remains optimistic and expects growth momentum to continue in fiscal 2012, based on reverse compensation from affiliates, strong demand of its content and streaming, retransmission consent and political advertising.
Due to its exposure in publishing, radio and television broadcasting, and outdoor billboard businesses, CBS remains highly susceptible to the advertising market. To mitigate this, the company is striving to add diverse revenue streams to hedge against economic cycles.
Revenue from retransmission keeps growing at a brisk pace. Further, the company is increasingly getting reverse compensation from its affiliates, marking a new source of revenue. The company also expects reverse compensation to expand in the coming quarters.
CBS secured deals worth hundreds of million, including a two-year deal with Netflix Inc (NFLX - Analyst Report), and also signed a non-exclusive licensing agreement with Amazon. Com. Inc (AMZN - Analyst Report). These measures backed CBS to generate revenue from shows that have already been broadcasted on TV years ago and facilitated the company in capitalizing its content.
CBS Corporation’s long-term agreements with the NFL, the NCAA, the SEC and the Grammy’s will generate stream of positive cash flows for the company in the long run.
Currently, we have a long-term Outperform rating on the stock. Moreover, CBS Corp. holds a Zacks #2 Rank, which translates into a short-term Buy rating.
French Ban Puts Monsanto in a Fix
Troubles cloud over Monsanto Company’s (MON - Analyst Report) European operations, as the French government expressed its intention to continue its ban on the genetically modified (GM) corn crops in 2012.
Despite a ruling from France's top administrative court--ordering the lifting of the ban in November 2011-- France intended to maintain its ban on the domestic cultivation of genetically-modified corn MON810 in 2012 on strong environmental issues. Keeping up with this intent, Environment Ministry of France has reportedly asked EU—for suspension of Monsanto GM corn approval for 2012, of late.
Since February 2008, the use of U.S. agricultural-biotech company Monsanto Co.'s MON810 corn variety has been banned by the French government on the grounds of health and environmental risks.
At the end of November 2011, the Conseil d'Etat administrative court ordered the ban lifted, ruling on a case brought by Monsanto and other companies, opposing the French agriculture ministry's ban on MON 810 corn.
However, recent scientific studies indubitably confirmed environmental hazards, which may be affixed with the planting of the specified variety. Hence, of late, the French environment ministry asked European Commission to suspend authorization to plant Monsanto's genetically modified MON810 corn.
MON810 corn was the only crop to have been granted permission for planting in the European Union, despite losing European and French court rulings. The seed patent for corn MON810 is owned by U.S.-based agro-biotech firm Monsanto Company, the leading global provider of agricultural products--operating in Seeds and Genomics and Agricultural Productivity segments.
Monsanto’s biotechnology research and innovations position it as a market leader above its peers, such as Syngenta AG (SYT - Analyst Report). The company maintains a strong cash position in the first quarter 2012, with net cash provided by operating activities recorded at $1,110 million versus $624 million, a year ago. Free cash flow increased to $856 million during the quarter ended November 30, 2011 compared with $500 million reported a year ago.
We currently maintain a long-term Outperform recommendation on the stock. Monsanto has a Zacks #2 Rank, which translates into a short-term Buy rating (1-3 months).
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Zacks Investment Research
800-767-3771 ext. 9339